IBDEI32I ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,48986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48986,1,3,0)
 ;;=3^Drug Therapy,Other Long Term Current Use
 ;;^UTILITY(U,$J,358.3,48986,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,48986,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,48987,0)
 ;;=Z76.0^^185^2428^71
 ;;^UTILITY(U,$J,358.3,48987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48987,1,3,0)
 ;;=3^Issue of Repeat Prescription
 ;;^UTILITY(U,$J,358.3,48987,1,4,0)
 ;;=4^Z76.0
 ;;^UTILITY(U,$J,358.3,48987,2)
 ;;=^5063297
 ;;^UTILITY(U,$J,358.3,48988,0)
 ;;=Z79.810^^185^2428^52
 ;;^UTILITY(U,$J,358.3,48988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48988,1,3,0)
 ;;=3^Drug Therapy,SERMs,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,48988,1,4,0)
 ;;=4^Z79.810
 ;;^UTILITY(U,$J,358.3,48988,2)
 ;;=^5063337
 ;;^UTILITY(U,$J,358.3,48989,0)
 ;;=Z79.51^^185^2428^47
 ;;^UTILITY(U,$J,358.3,48989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48989,1,3,0)
 ;;=3^Drug Therapy,Inhaled Steroids,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,48989,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,48989,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,48990,0)
 ;;=Z79.52^^185^2428^53
 ;;^UTILITY(U,$J,358.3,48990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48990,1,3,0)
 ;;=3^Drug Therapy,Systemic Steroids,Long Term Current Use
 ;;^UTILITY(U,$J,358.3,48990,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,48990,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,48991,0)
 ;;=R68.2^^185^2428^54
 ;;^UTILITY(U,$J,358.3,48991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48991,1,3,0)
 ;;=3^Dry Mouth,Unspec
 ;;^UTILITY(U,$J,358.3,48991,1,4,0)
 ;;=4^R68.2
 ;;^UTILITY(U,$J,358.3,48991,2)
 ;;=^5019552
 ;;^UTILITY(U,$J,358.3,48992,0)
 ;;=Z02.89^^185^2428^1
 ;;^UTILITY(U,$J,358.3,48992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48992,1,3,0)
 ;;=3^Administrative Exam Encounter
 ;;^UTILITY(U,$J,358.3,48992,1,4,0)
 ;;=4^Z02.89
 ;;^UTILITY(U,$J,358.3,48992,2)
 ;;=^5062645
 ;;^UTILITY(U,$J,358.3,48993,0)
 ;;=Z09.^^185^2428^56
 ;;^UTILITY(U,$J,358.3,48993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48993,1,3,0)
 ;;=3^F/U Exam After Treatment Encounter
 ;;^UTILITY(U,$J,358.3,48993,1,4,0)
 ;;=4^Z09.
 ;;^UTILITY(U,$J,358.3,48993,2)
 ;;=^5062668
 ;;^UTILITY(U,$J,358.3,48994,0)
 ;;=Z00.01^^185^2428^60
 ;;^UTILITY(U,$J,358.3,48994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48994,1,3,0)
 ;;=3^General Medical Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,48994,1,4,0)
 ;;=4^Z00.01
 ;;^UTILITY(U,$J,358.3,48994,2)
 ;;=^5062600
 ;;^UTILITY(U,$J,358.3,48995,0)
 ;;=Z00.00^^185^2428^61
 ;;^UTILITY(U,$J,358.3,48995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48995,1,3,0)
 ;;=3^General Medical Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,48995,1,4,0)
 ;;=4^Z00.00
 ;;^UTILITY(U,$J,358.3,48995,2)
 ;;=^5062599
 ;;^UTILITY(U,$J,358.3,48996,0)
 ;;=Z23.^^185^2428^69
 ;;^UTILITY(U,$J,358.3,48996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48996,1,3,0)
 ;;=3^Immunization Encounter
 ;;^UTILITY(U,$J,358.3,48996,1,4,0)
 ;;=4^Z23.
 ;;^UTILITY(U,$J,358.3,48996,2)
 ;;=^5062795
 ;;^UTILITY(U,$J,358.3,48997,0)
 ;;=Z03.89^^185^2428^81
 ;;^UTILITY(U,$J,358.3,48997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,48997,1,3,0)
 ;;=3^Observation for Suspected Diseases/Ruled Out Conditions
 ;;^UTILITY(U,$J,358.3,48997,1,4,0)
 ;;=4^Z03.89
 ;;^UTILITY(U,$J,358.3,48997,2)
 ;;=^5062656
 ;;^UTILITY(U,$J,358.3,48998,0)
 ;;=Z04.9^^185^2428^82
